TNF Historical Balance Sheet
| TNFA Stock | 1.27 0.09 6.62% |
Trend analysis of TNF Pharmaceuticals, balance sheet accounts such as Total Stockholder Equity of 17.1 M, Property Plant And Equipment Net of 45 K, Current Deferred Revenue of 320 K or Accounts Payable of 1.9 M provides information on TNF Pharmaceuticals,'s total assets, liabilities, and equity, which is the actual value of TNF Pharmaceuticals, to its prevalent stockholders. By breaking down trends over time using TNF Pharmaceuticals, balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining TNF Pharmaceuticals, latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether TNF Pharmaceuticals, is a good buy for the upcoming year.
TNF |
About TNF Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of TNF Pharmaceuticals, at a specified time, usually calculated after every quarter, six months, or one year. TNF Pharmaceuticals, Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of TNF Pharmaceuticals, and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which TNF currently owns. An asset can also be divided into two categories, current and non-current.
TNF Pharmaceuticals, Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of TNF Pharmaceuticals, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in TNF Pharmaceuticals, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on TNF Pharmaceuticals, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of TNF Pharmaceuticals, are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from TNF Pharmaceuticals,'s balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into TNF Pharmaceuticals, current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TNF Pharmaceuticals,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.At present, TNF Pharmaceuticals,'s Total Assets are projected to decrease significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 17.1 M, whereas Short and Long Term Debt Total is forecasted to decline to about 46.4 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 149.2K | 141.7K | 48.9K | 46.4K | Total Assets | 24.8M | 17.5M | 17.9M | 19.4M |
TNF Pharmaceuticals, balance sheet Correlations
Click cells to compare fundamentals
TNF Pharmaceuticals, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TNF Pharmaceuticals,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.48) | Return On Assets (0.32) | Return On Equity (2.98) |
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.